摘要
目的:针对门诊患者使用倍他乐克不规范的原因进行分析,为临床规范用药提供参考。方法:搜集2011年7月本院心内科普通门诊服用倍他乐克的患者病例,分析其中用药不当的原因以及各种具体表现。结果:373例使用倍他乐克的患者中,不规范用药者占9.39%,包括了用量、用法不正确、擅自减量、停药以及拒绝用药等12种用药不当的具体表现。在不规范用药的患者中,有9人随访间隔时间明显短于其余患者(P<0.05),但未被告知调整药物剂量。有8位患者年龄显著高于其余患者(P<0.05),由于独居或行动不便,随访间隔时间明显长于其余患者(P<0.05)。结论:倍他乐克使用不规范的情况并不少见,应当加强临床医师的教育以及对患者的宣教,增加用药的依从性,提高倍他乐克用药的规范性与合理性。
Objective: To investigate the incorrect usage of Betaloc in outpatients, in order to provide the instructions for usage of Betaloc. Methods: A total of 373 outpatients, who were outpatients in department of cardiology, Affiliated DrumTower Hospital, Nanjing University in July 2011, were collected. The causes and details of incorrect usage of Betaloc were summarized. Results: Of the 373 patients using Betaloc, 9.39% patients took the drug incorrectly. 12 manifestations were listed, including incorrect dosage and frequency, decrease or discontinuation of the drug without doctor's advice and refusal to the drug. Among the patients of incorrect drug use, 9 patients were followed up more closely than the others (P〈0.05), but they were not told to adjust the dosage of Betaloc; 8 patients were much older than the others significantly (P〈0.05) and they visited the clinic least (P〈0.05) for sake of inconvenience action or helplessness. Conclusions: It is common that Betaloc is incorrectly used in clinic. Thus, it is necessary to strengthen the education and publicity, and to improve normative rationality in the usage of Betaloc.
出处
《现代生物医学进展》
CAS
2013年第2期288-291,共4页
Progress in Modern Biomedicine